Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Nelson

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Oncotarget|October 1, 2016
Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse modelKei Kawaguchi, Takashi Murakami, Bartosz Chmielowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database AnalysisDanielle S Graham, Mykola Onyshchenko, Mark A Eckardt, et al.
Plos One|June 14, 2018
Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health AdministrationMakoto M Jones, Kevin L Winthrop, Scott D Nelson, et al.
JMIR Human Factors|October 26, 2021
A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability StudyThomas J Reese, Guilherme Del Fiol, Keaton Morgan, et al.
Journal of the American Medical Informatics Association : JAMIA|February 21, 2024
Leveraging explainable artificial intelligence to optimize clinical decision supportSiru Liu, Allison B McCoy, Josh F Peterson, et al.
Cell Cycle (Georgetown, Tex.)|April 21, 2017
Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomasPuja Kachroo, Peter S Pak, Harpavan S Sandha, et al.
Cancers|August 28, 2020
Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue SarcomaDanielle S Graham, Ritchell van Dams, Nicholas J Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomasVladimir Evilevitch, Wolfgang A Weber, William D Tap, et al.
Clinical Orthopaedics and Related Research|March 13, 2018
Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?Vishal Hegde, Zachary D C Burke, Howard Y Park, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Oncotarget|October 1, 2016
Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse modelKei Kawaguchi, Takashi Murakami, Bartosz Chmielowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database AnalysisDanielle S Graham, Mykola Onyshchenko, Mark A Eckardt, et al.
Plos One|June 14, 2018
Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health AdministrationMakoto M Jones, Kevin L Winthrop, Scott D Nelson, et al.
JMIR Human Factors|October 26, 2021
A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability StudyThomas J Reese, Guilherme Del Fiol, Keaton Morgan, et al.
Journal of the American Medical Informatics Association : JAMIA|February 21, 2024
Leveraging explainable artificial intelligence to optimize clinical decision supportSiru Liu, Allison B McCoy, Josh F Peterson, et al.
Cell Cycle (Georgetown, Tex.)|April 21, 2017
Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomasPuja Kachroo, Peter S Pak, Harpavan S Sandha, et al.
Cancers|August 28, 2020
Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue SarcomaDanielle S Graham, Ritchell van Dams, Nicholas J Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomasVladimir Evilevitch, Wolfgang A Weber, William D Tap, et al.
Clinical Orthopaedics and Related Research|March 13, 2018
Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?Vishal Hegde, Zachary D C Burke, Howard Y Park, et al.
Pageof 20